Showing results (1-10 of 89) with videos related to

Sort By:
Pageof 9
European Journal of Cell Biology|March 29, 2011
Third generation dendritic cell vaccines for tumor immunotherapyBernhard Frankenberger, Dolores J Schendel
Seminars in Cancer Biology|July 28, 2007
Immune suppression in renal cell carcinomaBernhard Frankenberger, Elfriede Noessner, Dolores J Schendel
Journal of Translational Medicine|February 28, 2012
NOD/scid IL-2Rg(null) mice: a preclinical model system to evaluate human dendritic cell-based vaccine strategies in vivoStefani Spranger, Bernhard Frankenberger, Dolores J Schendel
Molecular Therapy : the Journal of the American Society of Gene Therapy|June 1, 2005
RNA transfer by electroporation into mature dendritic cells leading to reactivation of effector-memory cytotoxic T lymphocytes: a quantitative analysisMiran Javorovic, Heike Pohla, Bernhard Frankenberger, et al.
Human Gene Therapy|July 8, 2005
Redirecting human T lymphocytes toward renal cell carcinoma specificity by retroviral transfer of T cell receptor genesBoris Engels, Elfriede Noessner, Bernhard Frankenberger, et al.
Journal of Translational Medicine|October 6, 2010
Three-day dendritic cells for vaccine development: antigen uptake, processing and presentationMaja Bürdek, Stefani Spranger, Susanne Wilde, et al.
Journal of Molecular Medicine (Berlin, Germany)|March 10, 2009
Harnessing innate and adaptive immunity for adoptive cell therapy of renal cell carcinomaChristiane Geiger, Elfriede Nössner, Bernhard Frankenberger, et al.
The Journal of Clinical Investigation|October 28, 2010
MHC-restricted fratricide of human lymphocytes expressing survivin-specific transgenic T cell receptorsMatthias Leisegang, Susanne Wilde, Stefani Spranger, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 13, 2012
Human antitumor CD8+ T cells producing Th1 polycytokines show superior antigen sensitivity and tumor recognitionSusanne Wilde, Daniel Sommermeyer, Matthias Leisegang, et al.
Pageof 9